DE2242103A1 - Verfahren zur isolierung und reinigung eines die bewegung von mg hoch 2+ in membranen beeinflussenden zytoplasmafaktors sowie die dabei erhaltenen produkte - Google Patents

Verfahren zur isolierung und reinigung eines die bewegung von mg hoch 2+ in membranen beeinflussenden zytoplasmafaktors sowie die dabei erhaltenen produkte

Info

Publication number
DE2242103A1
DE2242103A1 DE2242103A DE2242103A DE2242103A1 DE 2242103 A1 DE2242103 A1 DE 2242103A1 DE 2242103 A DE2242103 A DE 2242103A DE 2242103 A DE2242103 A DE 2242103A DE 2242103 A1 DE2242103 A1 DE 2242103A1
Authority
DE
Germany
Prior art keywords
starting material
activity
eluted
column
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2242103A
Other languages
German (de)
English (en)
Inventor
Pierre Volfin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of DE2242103A1 publication Critical patent/DE2242103A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2242103A 1971-08-27 1972-08-26 Verfahren zur isolierung und reinigung eines die bewegung von mg hoch 2+ in membranen beeinflussenden zytoplasmafaktors sowie die dabei erhaltenen produkte Pending DE2242103A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7131191A FR2151465A5 (enExample) 1971-08-27 1971-08-27

Publications (1)

Publication Number Publication Date
DE2242103A1 true DE2242103A1 (de) 1973-03-01

Family

ID=9082286

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2242103A Pending DE2242103A1 (de) 1971-08-27 1972-08-26 Verfahren zur isolierung und reinigung eines die bewegung von mg hoch 2+ in membranen beeinflussenden zytoplasmafaktors sowie die dabei erhaltenen produkte

Country Status (4)

Country Link
JP (1) JPS4835016A (enExample)
DE (1) DE2242103A1 (enExample)
FR (1) FR2151465A5 (enExample)
GB (1) GB1367187A (enExample)

Also Published As

Publication number Publication date
GB1367187A (en) 1974-09-18
FR2151465A5 (enExample) 1973-04-20
JPS4835016A (enExample) 1973-05-23

Similar Documents

Publication Publication Date Title
EP0158986B1 (de) Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
EP0209061B1 (de) Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
DE69434414T2 (de) Phosphatase oder ein entsprechendes derivat enthaltene pharmazeutische zusammensetzung
DE69121018T2 (de) Lipopeptid Deacylase
DE69108830T2 (de) Neue im schwein vorkommende physiologisch aktive peptide.
EP0207956B1 (de) Hirudin-pa und dessen derivate, verfahren zu deren herstellung und deren verwendung
DE69920877T2 (de) Antimikrobiell wirksame peptide
EP0064302B1 (de) Neues Peptid, Verfahren zu seiner Gewinnung und dieses enthaltendes Arzneimittel
DE69315388T2 (de) Aus bakteriellen Proteinen bestehender Extrakt, Verfahren zur dessen Herstellung und diesen Extrakt enthaltende pharmazeutische Zusammensetzung
CH676990A5 (enExample)
DE69411073T2 (de) Medizinisches Bleichmittel
DE69318495T2 (de) Verfahren zur Reinigung des Big-Endothelin Proteins
DE69331368T2 (de) Herstellung und Benützung eines Metastasehemmendes Proteines.
DE3781832T2 (de) C-terminal-alpha-amidierendes enzym und verfahren zu dessen herstellung und verwendung.
DE3884853T2 (de) Angiogenininhibitoren.
DE1076888B (de) Verfahren zur Gewinnung atmungsfoerdernder Wirkstoffe fuer therapeutische Zwecke
DE2043971C3 (de) Antitumorsubstanz aus haemolytischen Streptococcen
DE2720041A1 (de) Herzstaerkendes mittel
DE1518282C3 (de) Phe hoch 2 -Om hoch 8 -Oxytocin und Verfahren zu dessen Herstellung
DE3850407T2 (de) Protein mit inhibierender wirkung auf die entzündungserregende phospholipase a2.
DE2828933A1 (de) 3- eckige klammer auf (s)-1'-phenylaethylamino eckige klammer zu -propylaminobleomycin, verfahren zu seiner herstellung und diese verbindung enthaltendes arzneimittel
DE2639410C2 (de) Polypeptid VI-7501 mit Antitumorwirkung
DE69207037T2 (de) Verfahren zum Umsetzen von Fusionsprotein in aktiven menschlichen motiunähnlichen Polypeptiden und Reinigung von diesen Analogen
DE68908958T2 (de) Peptide.
DE2837588A1 (de) Anthopleurin-c, verfahren zu seiner gewinnung und pharmazeutische zubereitungen

Legal Events

Date Code Title Description
OHA Expiration of time for request for examination